Reproductive Medicine Unit, University College London Hospital, London NW1 2BU, UK.
EGA Institute from Women's Health, University College London, Londen WC1E 6AU, UK.
Medicina (Kaunas). 2024 Aug 21;60(8):1358. doi: 10.3390/medicina60081358.
In vitro fertilization (IVF) is an established option for the management of infertility in patients with endometriosis, though there remains ongoing debate around the extent to which endometriosis may compromise IVF treatment success, in which fertilization and preimplantation embryo development occur outside the pelvis. Whether endometriosis impacts oocyte and embryo quality and/or endometrial receptivity remains central to this debate. Here, we review the current literature relating to the impact of endometriosis on IVF outcomes and management strategies to consider when performing IVF treatment.
体外受精(IVF)是子宫内膜异位症患者不孕管理的既定选择,尽管围绕子宫内膜异位症在多大程度上可能影响 IVF 治疗成功仍存在争议,因为受精和胚胎着床前的胚胎发育都发生在骨盆外。子宫内膜异位症是否会影响卵子和胚胎质量以及/或子宫内膜容受性仍然是这场争论的核心。在这里,我们回顾了与子宫内膜异位症对 IVF 结局的影响以及在进行 IVF 治疗时需要考虑的管理策略相关的现有文献。